Why Is Edwards Lifesciences (EW) Up 7.5% Since Last Earnings Report?Zacks Investment Research • 02/25/22
Edwards Lifesciences Q4 Earnings Fall Short Of Expectations, Reaffirms FY22 OutlookBenzinga • 01/27/22
Edwards Lifesciences Corporation (EW) CEO Mike Mussallem on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 01/27/22
Why Edwards Lifesciences (EW) Might Surprise This Earnings SeasonZacks Investment Research • 01/21/22
Edwards Lifesciences (EW) to Report Q4 Results: Wall Street Expects Earnings GrowthZacks Investment Research • 01/19/22
Edwards Lifesciences (EW) Stock Sinks As Market Gains: What You Should KnowZacks Investment Research • 01/15/22
EDWARDS LIFESCIENCES TO PRESENT AT THE 40TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCEPRNewsWire • 01/05/22
EDWARDS RECEIVES FDA APPROVAL FOR SAPIEN 3 WITH ALTERRA PRESTENT FOR TRANSCATHETER PULMONIC VALVE REPLACEMENTPRNewsWire • 12/20/21
Edwards Announces Six-month Data From Transcatheter Tricuspid Replacement ProgramPRNewsWire • 11/06/21
TAVR with SAPIEN 3 Demonstrated as Economically Dominant Treatment Strategy Compared to Surgery in Partner 3 AnalysisPRNewsWire • 11/05/21
Edwards Lifesciences Corporation (EW) CEO Mike Mussallem on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 10/28/21